Get started
Author

Benoît Brethon

Observed names: B Brethon, B. Brethon, BRETHON, Benoît, Benoit Brethon, Benoît Brethon, Brethon, Benoît
Observed institutions: Università Cattolica del Sacro Cuore, Goethe University Frankfurt, The University of Western Australia, Université Paris Cité, University of Pavia, Hôpital Armand-Trousseau, Universitäts-Kinderklinik Würzburg, Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Princess Máxima Center, Hôpital Saint-Louis, Université Paris Diderot, Groupe Hospitalo-Universitaire Paris Nord, Laboratoire d'hématologie, Heinrich Heine University Düsseldorf, University of Milano-Bicocca, Medical University of Vienna, Charité - Universitätsmedizin Berlin, University of Tübingen
ORCID: 0000-0002-0663-3429
Observed ORCID: 0000-0002-0663-3429
OpenAlex ID: A5005516784
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
2016 · Arend von Stackelberg, Franco Locatelli, et al. · Journal of Clinical Oncology · 614
PDF
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia
2008 · Kimmo Porkka, Perttu Koskenvesa, et al. · Blood · 443
PDF
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
2006 · N Boissel, H Leroy, et al. · Leukemia · 357
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
2019 · Rob Pieters, Paola De Lorenzo, et al. · Journal of Clinical Oncology · 300
PDF
Treatment of childhood autoimmune haemolytic anaemia with rituximab
2001 · Pierre Quartier, Benoît Brethon, et al. · The Lancet · 281
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia
2023 · Inge M. van der Sluis, Paola de Lorenzo, et al. · New England Journal of Medicine · 221
Occurrence and Kinetics of False-PositiveAspergillusGalactomannan Test Results following Treatment with β-Lactam Antibiotics in Patients with Hematological Disorders
2006 · Alban Aubry, Raphael Porcher, et al. · Journal of Clinical Microbiology · 170
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
2017 · E. Mejstríková, O. Hrusak, et al. · Blood Cancer Journal · 146
PDF
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
2011 · Anne Bergeron, Raphaël Porcher, et al. · Blood · 145
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
2014 · E. Flex, M. Jaiswal, et al. · Human Molecular Genetics · 144
PDF
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
2021 · Sheena Mukkada, Nickhill Bhakta, et al. · The Lancet Oncology · 132
PDF
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
2017 · Arnaud Petit, Amélie Trinquand, et al. · Blood · 113
COVID‐19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms?
2020 · Nicolas André, Jérémie Rouger‐Gaudichon, et al. · Pediatric Blood & Cancer · 108
PDF
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
2020 · Franco Locatelli, Gerhard Zugmaier, et al. · Blood Cancer Journal · 98
PDF
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
2020 · Erica Brivio, Franco Locatelli, et al. · Blood · 97
PDF
Diagnosis of Fanconi anemia in patients with bone marrow failure
2009 · F. O. Pinto, T. Leblanc, et al. · Haematologica · 97
PDF
Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas
2006 · Eric de Kerviler, Cédric de Bazelaire, et al. · European Radiology · 80
Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients
2011 · Anne Bergeron, Raphaël Porcher, et al. · Journal of Clinical Microbiology · 77
PDF
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
2022 · Franco Locatelli, Gerhard Zugmaier, et al. · Blood Advances · 70
PDF
Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation
2019 · Brice Mouttet, Luciana Vinti, et al. · Haematologica · 68
PDF
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
2021 · Janine Stutterheim, Inge M. van der Sluis, et al. · Journal of Clinical Oncology · 62
PDF
Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia
2010 · H. Chappuy, A. Baruchel, et al. · Archives of Disease in Childhood · 61
Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia
2008 · Benoit Brethon, Karima Yakouben, et al. · British Journal of Haematology · 45
PDF
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation
2012 · R. Herbrecht, D. Caillot, et al. · Journal of Antimicrobial Chemotherapy · 42
Invasive infections due toCandida norvegensisandCandida inconspicua: report of 12 cases and review of the literature
2013 · Juliette Guitard, Adéla Angoulvant, et al. · Medical Mycology · 40
Works count: 126
Citation count: 4,697
H-index: 31
I10-index: 50
Year
Topic
Type